ID
45572
Beskrivning
Principal Investigator: Glen Weiss, MD, Translational Genomics Research Institute, Phoenix, AZ, USA MeSH: Carcinoma https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000657 In this study, we used NGS to identify somatic events in advanced stage cancer patients to demonstrate the feasibility for using this approach to improve patient treatment.
Länk
Nyckelord
Versioner (1)
- 2023-01-24 2023-01-24 - Dr. Christian Niklas
Rättsinnehavare
Glen Weiss, MD, Translational Genomics Research Institute, Phoenix, AZ, USA
Uppladdad den
24 januari 2023
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
dbGaP phs000657 NGS in Advanced Cancers
Subject ID, age, sex, and race of participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
- StudyEvent: SEV1
- Subject ID, consent group, and type of research where were involved participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
- Subject ID, sample ID, and sample use variables obtained from participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
- Subject ID, age, sex, and race of participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
- Sample ID, body site where sample was collected, analyte type, tumor status of sample, histological type of sample, primary tumor, metastasis, or transformed cell line, and primary tumor location of participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
Similar models
Subject ID, age, sex, and race of participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
- StudyEvent: SEV1
- Subject ID, consent group, and type of research where were involved participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
- Subject ID, sample ID, and sample use variables obtained from participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
- Subject ID, age, sex, and race of participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
- Sample ID, body site where sample was collected, analyte type, tumor status of sample, histological type of sample, primary tumor, metastasis, or transformed cell line, and primary tumor location of participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
C2348585 (UMLS CUI [1,2])
Inga kommentarer